Printer Friendly

Omega posts lower net income of USD72.2m for Q1 2019.

M2 PHARMA-May 8, 2019-Omega posts lower net income of USD72.2m for Q1 2019


Healthcare company Omega Healthcare Investors Inc (NYSE:OHI) stated on Tuesday its net income of USD72.2m (USD0.34 per common share) for the quarter ended 31 March 2019.

This marks a decrease in earnings when compared with net income of USD87.9m (USD0.42 per common share) for the corresponding period in 2018.

The company added the decline in net income for the quarter ended 31 March 2019 versus the prior year was primarily due to the reduction in gains on the sale of assets, an increase of costs related to the acquisition of MedEquities Realty Trust as well as an increase of of impairments

Operating revenues of USD223.7m were generated for the quarter ended 31 March 2019, up over operating revenues of USD220.2m for the same period in 2018.

((Comments on this story may be sent to

COPYRIGHT 2019 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Article Type:Financial report
Date:May 8, 2019
Previous Article:Actinium Pharmaceuticals names new chief business officer.
Next Article:US FDA Approves Vyndaqel and Vyndamax for Use in Patients with Transthyretin Amyloid Cardiomyopathy, a Rare and Fatal Disease.

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |